https://clinicaltrials.gov/ct2/show/NCT04025554?type=Intr&cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14
Condition : Multiple Sclerosis
Intervention : Drug: Anakinra
Sponsor : National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
NCT04025554
Fri, 19 Jul 2019 12:00:00 EDT
First Added: 07/19/19 06:45AM